Dr. Reddy’s Laboratories Ltd. ADR (NYSE: RDY) is 5.56% higher on its value in year-to-date trading and has touched a low of $13.26 and a high of $16.89 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The RDY stock was last observed hovering at around $14.46 in the last trading session, with the day’s gains setting it 0.23%.
Currently trading at $14.69, the stock is 2.63% and -1.35% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.52 million and changing 1.59% at the moment leaves the stock -2.86% off its SMA200. RDY registered 10.14% gain for a year compared to 6-month loss of 2.44%. The firm has a 50-day simple moving average (SMA 50) of $14.9096 and a 200-day simple moving average (SMA200) of $15.12464.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 3.16% gain in the last 1 month and extending the period to 3 months gives it a -7.64%, and is 1.52% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.09% over the week and 1.34% over the month.
Dr. Reddy’s Laboratories Ltd. ADR (RDY) has around 27048 employees, a market worth around $12.24B and $3.60B in sales. Current P/E ratio is 19.15 and Fwd P/E is 18.03. Profit margin for the company is 17.79%. Distance from 52-week low is 10.75% and -13.04% from its 52-week high. The company has generated returns on investments over the last 12 months (17.14%).
The EPS is expected to grow by 2.09% this year.
Dr. Reddy’s Laboratories Ltd. ADR (RDY) Top Institutional Holders
The shares outstanding are 834.38M, and float is at 833.01M with Short Float at 1.33%.
The top institutional shareholder in the company is ROBECO INSTITUTIONAL ASSET MANAGEMENT B.V. with over 2.07 million shares valued at $157.65 million. The investor’s holdings represent 1.2427% of the RDY Shares outstanding. As of 2024-06-30, the second largest holder is ROYAL BANK OF CANADA with 2.06 million shares valued at $156.61 million to account for 1.2345 of the shares outstanding. The other top investors are MORGAN STANLEY which holds 2.03 million shares representing 1.2191% and valued at over $154.67 million, while RENAISSANCE TECHNOLOGIES LLC holds 1.1984 of the shares totaling 2.0 million with a market value of $152.04 million.
Dr. Reddy’s Laboratories Ltd. ADR (RDY) Insider Activity
#####
